Generation of Recombinant Vaccinia Viruses
Current Protocols in Protein Science · 2017-08 · 89 (1)
DOI: 10.1002/cpps.33 ↗At a glance
Journal article in Current Protocols in Protein Science, published online on 2018-02-13. Written by Linda S Wyatt and 2 co-authors. Institution: Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland. Cited 23 times so far (Crossref); 40 references. The full text is freely available in PubMed Central. Funded by: Intramural NIH HHS.
Abstract (original language)
This unit describes how to infect cells with vaccinia virus and then transfect them with a plasmid‐transfer vector or PCR fragment to generate a recombinant virus. Selection and screening methods used to isolate recombinant viruses and a method for the amplification of recombinant viruses are described. Finally, a method for live immunostaining that has been used primarily for detection of recombinant modified vaccinia virus Ankara (MVA) is presented. © 2017 by John Wiley & Sons, Inc.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Funding
- Intramural NIH HHS
Cite
APA
Wyatt, L. S., Earl, P. L., & Moss, B. (2017). Generation of Recombinant Vaccinia Viruses. Current Protocols in Protein Science, 89(1). https://doi.org/10.1002/cpps.33
Vancouver
Wyatt LS, Earl PL, Moss B. Generation of Recombinant Vaccinia Viruses. Current Protocols in Protein Science. 2017;89(1). doi:10.1002/cpps.33
BibTeX
@article{Wyatt2017,
author = {Wyatt, Linda S and Earl, Patricia L and Moss, Bernard},
title = {Generation of Recombinant Vaccinia Viruses},
journal = {Current Protocols in Protein Science},
year = {2017},
volume = {89},
number = {1},
doi = {10.1002/cpps.33}
}
EUVIMED